InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Goddard Glenn, Chief Financial Officer. Director active across 1 companies, notably Intellia Therapeutics, Inc.. In total, 7 reports have been logged. The latest transaction was disclosed on 7 September 2021 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
3,062 shares
Common Stock
SEC:0001209191-22-015917:0·
€42,8653,482 shares@ €12.31050.0022% mcap9.5% of flow
Common Stock
SEC:0001209191-21-055347·
€42,8653,482 shares@ €12.31050.0022% mcap4.7% of flow
Common Stock
SEC:0001209191-21-055347:0·
€84,9415,200 shares@ €16.33480.0044% mcap18.7% of flow
Common Stock
SEC:0001209191-21-054315·
€84,9415,200 shares@ €16.33480.0044% mcap9.4% of flow
Common Stock
SEC:0001209191-21-054315:0·
€325,62420,000 shares@ €16.28120.017% mcap71.8% of flow
Common Stock
SEC:0001209191-21-050225·
€325,62420,000 shares@ €16.28120.017% mcap35.9% of flow
Common Stock
SEC:0001209191-21-050225:0·
7 of 7 declarations
About Goddard Glenn
Glenn Goddard is Executive Vice President and Chief Financial Officer at Intellia Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning, performance analysis, and regulatory compliance. His expertise in finance is crucial to support growth and optimize financial results. Glenn also plays a key role in investment strategy and risk management.
